Kim Brixen

12.5k total citations
241 papers, 9.2k citations indexed

About

Kim Brixen is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kim Brixen has authored 241 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Orthopedics and Sports Medicine, 74 papers in Oncology and 66 papers in Molecular Biology. Recurrent topics in Kim Brixen's work include Bone health and osteoporosis research (109 papers), Bone health and treatments (68 papers) and Bone Metabolism and Diseases (37 papers). Kim Brixen is often cited by papers focused on Bone health and osteoporosis research (109 papers), Bone health and treatments (68 papers) and Bone Metabolism and Diseases (37 papers). Kim Brixen collaborates with scholars based in Denmark, Belgium and Norway. Kim Brixen's co-authors include Leif Mosekilde, Bo Abrahamsen, Stinus Hansen, Anne Pernille Hermann, Marianne Andersen, Jeppe Gram, Claus Hagen, Vikram Vinod Shanbhogue, Henning K. Nielsen and Peter Vestergaard and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Allergy and Clinical Immunology and Journal of the American Geriatrics Society.

In The Last Decade

Kim Brixen

235 papers receiving 8.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kim Brixen	3.8k	2.5k	2.2k	1.7k	1.6k	241	9.2k
Jens Bollerslev	1.8k 0.5×	2.0k 0.8×	3.3k 1.5×	2.7k 1.5×	2.0k 1.2×	280	10.0k
Stefan Goemaere	4.0k 1.1×	2.7k 1.1×	2.7k 1.2×	1.5k 0.8×	1.2k 0.8×	179	8.9k
Östen Ljunggren	2.5k 0.6×	2.3k 0.9×	3.6k 1.6×	2.7k 1.6×	1.6k 1.0×	222	10.9k
Mattias Lorentzon	5.3k 1.4×	2.1k 0.8×	2.8k 1.3×	1.5k 0.8×	2.5k 1.6×	259	10.3k
Paweł Szulc	4.3k 1.1×	1.6k 0.6×	2.0k 0.9×	1.1k 0.6×	1.7k 1.0×	177	8.3k
Fernando Rivadeneira	2.7k 0.7×	1.2k 0.5×	3.0k 1.3×	1.0k 0.6×	1.4k 0.9×	274	10.8k
Salvatore Minisola	4.3k 1.1×	3.2k 1.3×	2.1k 0.9×	999 0.6×	1.9k 1.2×	307	10.1k
Jean‐Philippe Bonjour	3.4k 0.9×	1.2k 0.5×	1.9k 0.9×	903 0.5×	862 0.5×	138	7.9k
Sara J. Achenbach	2.9k 0.8×	1.7k 0.7×	1.4k 0.6×	885 0.5×	2.4k 1.5×	184	8.5k
Christopher S. Kovács	3.2k 0.8×	1.6k 0.6×	1.8k 0.8×	1.2k 0.7×	1.5k 1.0×	141	11.3k

Countries citing papers authored by Kim Brixen

Since Specialization

Citations

This map shows the geographic impact of Kim Brixen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Brixen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Brixen more than expected).

Fields of papers citing papers by Kim Brixen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Brixen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Brixen. The network helps show where Kim Brixen may publish in the future.

Co-authorship network of co-authors of Kim Brixen

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Brixen. A scholar is included among the top collaborators of Kim Brixen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Brixen. Kim Brixen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mathiesen, Jes Sloth, Jens Peter Kroustrup, Peter Vestergaard, et al.. (2019). Completeness of<em> RET</em> testing in patients with medullary thyroid carcinoma in Denmark 1997–2013: a nationwide study. Clinical Epidemiology. Volume 11. 93–99. 7 indexed citations

Mathiesen, Jes Sloth, Jens Peter Kroustrup, Peter Vestergaard, et al.. (2019). Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997–2014: A Nationwide Study. Thyroid. 29(3). 368–377. 43 indexed citations

Rubin, Katrine Hass, Mette Juel Rothmann, Teresa Holmberg, et al.. (2017). Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study. Osteoporosis International. 29(3). 567–578. 72 indexed citations

Folkestad, Lars, Jannie Dahl Hald, Annette Kjær Ersbøll, et al.. (2016). Fracture Rates and Fracture Sites in Patients With Osteogenesis Imperfecta: A Nationwide Register-Based Cohort Study. Journal of Bone and Mineral Research. 32(1). 125–134. 97 indexed citations

Folkestad, Lars, Jannie Dahl Hald, Vladimir Canudas‐Romo, et al.. (2016). Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register-Based Nationwide Cohort Study. Journal of Bone and Mineral Research. 31(12). 2159–2166. 90 indexed citations

Holm, Bente, et al.. (2015). Non-intercepted dose errors in prescribing anti-neoplastic treatment: a prospective, comparative cohort study. Annals of Oncology. 26(5). 981–986. 23 indexed citations

Brixen, Kim, Roland Chapurlat, Angela M. Cheung, et al.. (2013). Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 98(2). 571–580. 95 indexed citations

Rubin, Katrine Hass, Teresa Holmberg, Anne Pernille Hermann, Bo Abrahamsen, & Kim Brixen. (2013). Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review. Journal of Bone and Mineral Research. 28(8). 1701–1717. 151 indexed citations

Frost, M., Bo Abrahamsen, Torben Leo Nielsen, et al.. (2010). Adiponectin and Peak Bone Mass in Men: A Cross-Sectional, Population-Based Study. Calcified Tissue International. 87(1). 36–43. 10 indexed citations

10.

Frost, M., Torben Leo Nielsen, K. Wraae, et al.. (2010). Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution. European Journal of Endocrinology. 163(3). 407–412. 24 indexed citations

11.

Bruyère, Olivier, Christian Roux, Johann Detilleux, et al.. (2008). Relationship Between Bone Mineral Density Changes and Fracture Risk Reduction in Patients Treated With Strontium Ranelate. Obstetrical & Gynecological Survey. 63(1). 36–37. 1 indexed citations

12.

Nielsen, Torben Leo, K. Wraae, Bo Abrahamsen, et al.. (2007). Population-based reference values for bone mineral density in young men. Osteoporosis International. 18(11). 1507–1514. 43 indexed citations

13.

Seeman, Ego, B. Vellas, C. L. Benhamou, et al.. (2006). Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis. Ghent University Academic Bibliography (Ghent University). 5 indexed citations

14.

Bruyère, Olivier, Christian Roux, Jorge B. Cannata‐Andía, et al.. (2006). Associations between increase in bone mineral density and decrease in clinical vertebral fracture incidence during a treatment with strontium ranelate. Open Repository and Bibliography (University of Liège). 2 indexed citations

15.

Seeman, Ego, B. Vellas, J. P. Aquino, et al.. (2006). Strontium ranelate reduces the risk of fracture in elderly women with osteoporosis in the first year of treatment. Osteoporosis International. 17. 209. 1 indexed citations

16.

Seeman, Ego, Jean‐Pierre Devogelaer, R. G. Spector, et al.. (2004). Strontium ranelate: The first anti-osteoporotic agent to reduce the risk of vertebral fracture in patients with lumbar osteopenia. Osteoporosis International. 15(6). 507–508. 3 indexed citations

17.

Adámi, S., K Hoszowski, Patrice Fardellone, et al.. (2004). Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in Caucasian women with post-menopausal osteoporosis.. Calcified Tissue International. 74. 1 indexed citations

18.

Reginster, Jean‐Yves, R Lorenc, Tim D. Spector, et al.. (2003). Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis. Osteoporosis International. 14. 2 indexed citations

19.

Bladbjerg, Else‐Marie, Jonna Skov Madsen, Søren Risom Kristensen, et al.. (2003). Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study. Journal of Thrombosis and Haemostasis. 1(6). 1208–1214. 28 indexed citations

20.

Brixen, Kim, et al.. (1993). Growth Hormone (GH) and Adult Bone Remodeling: The Potential Use of GH in Treatment of Osteoporosis. Journal of Pediatric Endocrinology and Metabolism. 6(1). 65–71. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact